Inherent Biosciences is a startup. Brouky records 1 investor associated with the company.
Inherent Biosciences develops molecular diagnostic tests that combine epigenetic biomarkers with AI-driven analysis to assess and improve reproductive health and fertility outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.